Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 10.88%5.17B | -18.90%6.67B | 0.02%5.01B | 6.76%5.45B | 41.96%4.66B | 119.84%8.22B | 96.16%5.01B | 49.63%5.1B | -24.36%3.29B | 18.66%3.74B |
Transactional financial assets | 21.69%5.56B | 103.26%5.22B | 40.68%3.61B | 60.33%3.79B | 12.27%4.57B | -21.08%2.57B | 0.77%2.57B | 0.69%2.36B | 111.69%4.07B | 68.87%3.25B |
Notes receivable and accounts receivable | 6.81%9.3B | 7.32%11.04B | 0.31%10.28B | -3.12%9.71B | -11.03%8.71B | -17.60%10.29B | -0.21%10.25B | -2.72%10.02B | 26.51%9.79B | 12.14%12.49B |
-Notes receivable | 18.58%129.98M | 11.71%136.57M | 2.93%89.07M | 3.81%39.18M | 15.78%109.61M | 2.34%122.25M | 39.68%86.54M | -29.72%37.74M | 44.95%94.67M | -41.21%119.45M |
-Accounts receivable | 6.66%9.17B | 7.26%10.9B | 0.29%10.19B | -3.15%9.67B | -11.29%8.6B | -17.80%10.17B | -0.45%10.16B | -2.57%9.99B | 26.36%9.69B | 13.13%12.37B |
Other receivables (including interest and dividends) | 40.81%232.26M | 109.90%138.64M | -10.34%187.53M | -13.12%173.93M | -20.06%164.95M | -62.05%66.05M | 30.79%209.17M | 10.64%200.2M | 28.05%206.33M | 4.65%174.04M |
-Dividend receivable | 23.33%4.17M | 21.40%4.17M | -73.25%6.98M | -33.85%19.48M | --3.38M | 524.99%3.44M | 175.76%26.09M | 465.63%29.45M | --0 | --549.72K |
-Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Other receivable | ---- | ---- | ---- | -9.54%154.45M | ---- | -63.91%62.61M | ---- | -2.84%170.75M | --206.33M | 4.32%173.49M |
Contractual assets | 29.57%3.22B | 14.18%2.57B | -2.38%3.31B | 22.51%3.23B | -3.54%2.48B | -6.07%2.25B | 7.74%3.4B | -3.65%2.64B | 10.91%2.57B | 21.71%2.4B |
Advance payment | 42.14%184.26M | -42.18%52.86M | -26.20%164.68M | -18.30%88.3M | -9.25%129.63M | 106.00%91.43M | -54.19%223.15M | -68.86%108.08M | -69.50%142.85M | -18.11%44.38M |
Inventories | 23.63%1.25B | 35.42%1.01B | 21.85%1.22B | 27.45%1.23B | 2.40%1.01B | -12.45%748.87M | 14.31%1B | 7.21%964.28M | -5.66%987.85M | 14.06%855.41M |
Receivable financing | 162.43%256.3M | -29.97%131.18M | 46.38%216.63M | 160.29%209.38M | 132.35%97.67M | 108.28%187.3M | 119.99%147.99M | -36.21%80.44M | -30.75%42.03M | 357.99%89.93M |
Non-current assets due within one year | 122.33%4.54M | 119.63%4.49M | ---- | ---- | -4.01%2.04M | 4.16%2.04M | --2.13M | --2.13M | --2.13M | --1.96M |
Other current assets | 16.36%463.8M | -3.48%352.74M | 73.60%346.15M | 37.47%374.86M | 48.94%398.6M | 35.27%365.46M | 35.95%199.4M | 63.52%272.69M | -24.39%267.63M | -28.16%270.17M |
Total current assets | 15.35%25.64B | 9.70%27.19B | 5.87%24.35B | 11.49%24.26B | 4.04%22.23B | 6.33%24.79B | 13.53%23B | 6.02%21.76B | 16.03%21.37B | 19.26%23.31B |
Non Current assets | ||||||||||
Debt investment | 2.99%1.07B | 3.02%1.06B | 3.05%1.05B | 3.07%1.04B | 3.58%1.04B | --1.03B | --1.02B | --1.01B | --1B | ---- |
Other equity investment | 5.04%199.51M | 5.33%199.75M | -2.50%179.61M | -1.61%182.25M | 6.96%189.93M | 5.57%189.64M | 5.94%184.21M | 14.94%185.23M | 12.34%177.57M | 13.23%179.64M |
Investment real estate | 11.66%9.34M | 9.52%11.23M | 52.42%8.8M | -53.14%8.59M | -7.06%8.37M | -3.46%10.25M | -65.20%5.77M | 0.98%18.32M | 14.86%9M | 15.99%10.62M |
Long-term equity investment | 45.06%4.42B | 48.91%4.31B | 43.09%4.13B | 36.83%3.9B | 32.21%3.05B | 29.00%2.89B | 30.78%2.89B | 35.71%2.85B | 9.79%2.31B | 7.39%2.24B |
Long term receivable account | -23.82%28.36M | -22.89%29.51M | -15.15%35.09M | -14.66%36.16M | -14.20%37.22M | -13.77%38.27M | -16.39%41.35M | -15.77%42.37M | -15.38%43.38M | -15.01%44.38M |
Fixed assets | ---- | ---- | ---- | 31.20%10.72B | ---- | 23.03%10.54B | ---- | -6.41%8.17B | ---- | -3.20%8.57B |
Fixed assets liquidation | ---- | ---- | ---- | 183.63%13.87M | ---- | 189.78%17.25M | ---- | 5.71%4.89M | ---- | -12.96%5.95M |
Constru in process | ---- | ---- | ---- | -55.61%1.1B | ---- | -54.93%912.28M | ---- | 110.36%2.49B | ---- | 108.80%2.02B |
Intangible assets | -2.42%2.27B | -2.57%2.29B | -0.16%2.29B | -0.42%2.31B | -0.12%2.32B | 0.30%2.35B | 4.92%2.29B | 4.41%2.32B | 24.44%2.33B | 24.12%2.35B |
Development expenditure | ---- | ---- | ---- | 88.49%4.64M | 70.46%4.64M | 70.46%4.64M | -58.02%2.56M | -57.32%2.46M | 84.96%2.72M | 84.96%2.72M |
Long deferred expense | -5.82%812.22M | -3.61%850.99M | 24.73%888.78M | 30.07%865.97M | 49.87%862.45M | 49.08%882.91M | 22.98%712.54M | 12.11%665.77M | 6.11%575.46M | -10.88%592.24M |
Deferred tax assets | 4.53%106.74M | -17.39%93.68M | -43.91%85.07M | -31.61%96.18M | -73.65%102.11M | -71.21%113.4M | -50.21%151.66M | -51.32%140.64M | 25.06%387.57M | 27.61%393.89M |
Usufruct assets | 9.88%1.19B | 1.62%1.15B | 14.86%1.15B | 16.30%1.2B | 8.92%1.08B | 19.49%1.13B | 16.46%999.93M | 22.67%1.03B | 19.72%996.03M | 10.09%947.66M |
Other non current assets | --18.27M | --18.27M | ---- | --33M | ---- | ---- | ---- | ---- | ---- | ---- |
Total non current assets | 10.49%22.35B | 10.90%22.31B | 11.62%21.65B | 13.65%21.52B | 10.81%20.23B | 15.89%20.12B | 17.79%19.39B | 16.87%18.93B | 14.35%18.26B | 7.65%17.36B |
Total assets | 13.04%48B | 10.24%49.5B | 8.50%46B | 12.50%45.78B | 7.16%42.46B | 10.41%44.91B | 15.44%42.4B | 10.81%40.69B | 15.25%39.63B | 14.01%40.67B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | ---- | ---- | ---- | ---- | --41.33M | -0.88%57.02M | ---- | ---- | ---- | -28.18%57.52M |
Notes payable and accounts payable | 21.92%11.18B | 8.78%13.84B | 9.57%10.33B | 36.44%11.74B | 5.48%9.17B | 12.76%12.72B | 20.02%9.42B | -3.55%8.6B | 13.36%8.69B | 15.29%11.28B |
-Notes payable | ---- | ---- | -92.48%3.44M | -94.31%2.1M | -60.58%7.22M | -53.90%25.34M | -48.21%45.79M | -49.32%36.85M | -56.80%18.32M | -57.89%54.96M |
-Accounts payable | 22.02%11.18B | 9.00%13.84B | 10.07%10.32B | 37.01%11.73B | 5.62%9.16B | 13.09%12.7B | 20.80%9.38B | -3.18%8.56B | 13.75%8.68B | 16.28%11.23B |
Contract liabilities | 58.16%1.4B | 90.78%782.6M | -20.03%1.36B | -23.86%1.01B | -46.28%885.74M | -21.86%410.21M | 32.49%1.7B | 21.77%1.32B | 67.76%1.65B | 22.17%524.99M |
Advance receipts | -54.92%9.96M | -27.73%3.66M | -22.44%15.49M | 68.19%16.03M | 102.96%22.1M | 168.40%5.07M | 79.07%19.96M | 9.07%9.53M | 10.89%10.89M | -52.57%1.89M |
Salaries payable | 1.46%1.39B | -0.33%989.84M | 7.21%2.06B | 9.29%1.71B | 1.22%1.37B | -3.06%993.15M | 9.01%1.92B | 15.02%1.57B | 12.91%1.35B | 3.53%1.02B |
Taxs payable | 4.87%471.81M | 9.81%920.83M | -22.37%457.37M | 0.42%525.3M | -15.79%449.9M | -9.92%838.53M | -1.53%589.19M | -9.08%523.11M | -14.60%534.26M | 1.32%930.89M |
Other payable (including interest and dividends) | 7.29%571.37M | -1.82%573.49M | -10.64%538.76M | -62.38%560.75M | -4.57%532.57M | -11.81%584.1M | -18.55%602.88M | 14.13%1.49B | -14.43%558.1M | -2.99%662.32M |
-Dividend payable | 29.08%14.28M | -35.41%14.28M | -69.52%14.28M | -97.33%24.99M | --11.06M | 63.26%22.11M | 58.83%46.86M | 57.77%935.72M | ---- | 577.12%13.54M |
-Other payable | ---- | ---- | ---- | -3.46%535.75M | ---- | -13.38%561.99M | ---- | -22.17%554.97M | ---- | -4.70%648.78M |
Non current liabilities due within one year | -56.73%331.82M | -3.48%750.08M | -36.36%364.48M | 41.07%708.61M | 193.09%766.85M | 219.06%777.11M | 518.69%572.74M | 330.86%502.31M | 128.15%261.64M | 92.41%243.56M |
Other current liabilities | 54.45%402.5M | 29.36%294.65M | 174.88%399.23M | 156.63%339.09M | 149.85%260.61M | 87.52%227.79M | 55.64%145.24M | 33.16%132.13M | 41.01%104.31M | 169.23%121.47M |
Total current liabilities | 16.74%15.76B | 9.27%18.16B | 3.64%15.52B | 17.37%16.6B | 2.53%13.5B | 11.89%16.62B | 19.68%14.97B | 4.34%14.15B | 14.97%13.16B | 13.68%14.85B |
Current liabilities | ||||||||||
Long term loan | 37.91%2.25B | 33.96%2.02B | 40.52%2.18B | 25.26%1.83B | 22.92%1.64B | 29.76%1.51B | 240.61%1.55B | 283.94%1.46B | 257.23%1.33B | 215.13%1.16B |
Long term account payable | ---- | ---- | ---- | -15.08%206.14M | ---- | -14.09%224.4M | ---- | 12,961.50%242.76M | ---- | 13,954.51%261.22M |
Long term salaries pay | 19.03%97.99M | 18.39%100.86M | -6.48%75.92M | -6.08%78.97M | -5.93%82.33M | -5.81%85.19M | 103.91%81.18M | 96.50%84.08M | 91.12%87.52M | 83.69%90.45M |
Estimate liabilities | 2,067.89%26.7M | 2,112.95%27.26M | --1.23M | --1.23M | --1.23M | --1.23M | ---- | ---- | ---- | ---- |
Deferred tax liabilities | -4.10%39.54M | 1.38%38.56M | -11.09%37.78M | -6.52%38.51M | -85.50%41.23M | -87.29%38.04M | -82.23%42.5M | -82.63%41.2M | 19.44%284.34M | 21.47%299.26M |
Long term deferred income | 14.15%185.5M | 15.46%179.7M | -0.44%172.21M | 6.45%170.49M | -1.51%162.5M | -3.87%155.64M | -7.91%172.98M | -16.20%160.16M | -21.88%164.99M | -18.71%161.9M |
Lease liabilities | 5.94%999.31M | -1.93%929.45M | 10.40%957.08M | 7.54%1.01B | 12.68%943.27M | 21.42%947.7M | 13.97%866.92M | 31.80%936.41M | 19.68%837.12M | 11.25%780.53M |
Other non current liabilities | ---- | ---- | ---- | ---- | -26.00%19.01M | -1.85%25M | 0.00%25M | 0.00%25M | 2.74%25.69M | -0.75%25.47M |
Total non current liabilities | 20.71%3.74B | 16.69%3.48B | 21.80%3.63B | 12.94%3.33B | 3.95%3.1B | 7.34%2.98B | 74.01%2.98B | 85.70%2.95B | 87.10%2.98B | 74.58%2.78B |
Total liabilities | 17.48%19.5B | 10.40%21.64B | 6.65%19.15B | 16.60%19.94B | 2.80%16.6B | 11.17%19.6B | 26.21%17.95B | 12.88%17.1B | 23.79%16.15B | 20.30%17.63B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%10.17B | 0.00%10.17B | 0.00%10.17B | 0.00%10.17B | 0.00%10.17B | 0.00%10.17B | 0.00%10.17B | 0.00%10.17B | 0.00%10.17B | 0.00%10.17B |
Capital reserve funds | 0.06%1.73B | 0.06%1.73B | 0.07%1.73B | -0.01%1.73B | -0.02%1.73B | 0.06%1.73B | 0.05%1.73B | 0.01%1.73B | -0.09%1.73B | -0.68%1.73B |
Surplus reserve funds | 11.60%2.02B | 11.60%2.02B | 16.36%1.81B | 16.36%1.81B | 16.36%1.81B | 16.36%1.81B | 11.82%1.55B | 11.82%1.55B | 11.82%1.55B | 11.82%1.55B |
Retained profit | 21.56%13.65B | 21.71%13.06B | 22.42%12.3B | 21.53%11.23B | 22.36%11.23B | 22.40%10.73B | 20.25%10.05B | 22.39%9.24B | 24.47%9.18B | 23.93%8.76B |
Other composite income | 2.77%153.51M | 10.17%160.08M | -46.98%91.16M | -19.57%154.99M | 105.19%149.37M | 48.12%145.29M | 45.41%171.95M | 4,058.37%192.71M | 180.60%72.8M | 217.42%98.1M |
Specific reserves | -20.74%60.79M | -32.53%38.15M | -9.72%84.42M | 23.16%85.68M | 72.59%76.69M | 157.58%56.54M | 112.25%93.51M | 73.77%69.57M | 36.23%44.44M | 4.35%21.95M |
Shareholders equity without minority interests | 10.42%27.77B | 10.29%27.16B | 10.18%26.17B | 9.68%25.17B | 10.62%25.15B | 10.30%24.63B | 8.99%23.76B | 9.93%22.94B | 10.40%22.74B | 9.98%22.33B |
Minority interests | 2.05%726.32M | 3.52%700.82M | -1.29%681.79M | 3.99%674.03M | -3.93%711.71M | -4.89%677.02M | -2.36%690.69M | -7.60%648.18M | -0.03%740.84M | -0.67%711.82M |
Total shareholder equity | 10.19%28.5B | 10.11%27.86B | 9.85%26.85B | 9.52%25.84B | 10.16%25.87B | 9.83%25.3B | 8.63%24.45B | 9.36%23.59B | 10.04%23.48B | 9.62%23.04B |
Total liabilityies and equity | 13.04%48B | 10.24%49.5B | 8.50%46B | 12.50%45.78B | 7.16%42.46B | 10.41%44.91B | 15.44%42.4B | 10.81%40.69B | 15.25%39.63B | 14.01%40.67B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.